Mapping onto Eq-5 D for patients in poor health
暂无分享,去创建一个
Donna Rowen | Elly A Stolk | J. Brazier | D. Rowen | M. Versteegh | E. Stolk | John E Brazier | Matthijs M Versteegh
[1] Haomiao Jia,et al. Mapping the SF-12 to the EuroQol EQ-5D Index in a National US Sample , 2004, Medical decision making : an international journal of the Society for Medical Decision Making.
[2] Aki Tsuchiya,et al. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures , 2010, The European Journal of Health Economics.
[3] J. Baars,et al. Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. , 2002, Blood.
[4] M. King. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30 , 1996, Quality of Life Research.
[5] Nick Kontodimopoulos,et al. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[6] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.
[7] John Brazier,et al. Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[8] Andrew Briggs,et al. Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences , 2010, The European Journal of Health Economics.
[9] Aki Tsuchiya,et al. Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis. , 2007, Arthritis and rheumatism.
[10] J. Fries,et al. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. , 2003, The Journal of rheumatology.
[11] Bonnie Bruce,et al. The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications , 2003, Health and quality of life outcomes.
[12] M. van der Pol,et al. Mapping the EORTC QLQ C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[13] P. Stalmeier,et al. The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies. , 2006, Health economics.
[14] M. Versteegh,et al. Mapping QLQ-C 30 , HAQ , and MSIS-29 on EQ-5 D , 2012 .
[15] J. Brazier,et al. A comparison of the EQ-5D and SF-6D across seven patient groups. , 2004, Health economics.
[16] J. Hazes,et al. Work and sick leave among patients with early inflammatory joint conditions. , 2008, Arthritis and rheumatism.
[17] Oliver Rivero-Arias,et al. Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome , 2010, Medical decision making : an international journal of the Society for Medical Decision Making.
[18] P. Sonneveld,et al. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] J. Kopec,et al. A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis , 2004, Medical care.
[20] Julia Earnshaw,et al. NICE Guide to the Methods of Technology Appraisal , 2012, PharmacoEconomics.
[21] M. Kosinski,et al. Mapping MOS Sleep Scale scores to SF‑6D utility index , 2007, Current medical research and opinion.
[22] M. Versteegh,et al. Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D , 2012, Medical decision making : an international journal of the Society for Medical Decision Making.
[23] John Brazier,et al. Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? , 2009, Health and quality of life outcomes.
[24] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.